Loading the session
Loading the session
Loading instrument
$31.65
+0.00%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: +20.0% (SPY −1.6%, XLV +13.5%). 3 months: +44.2% (SPY −0.4%, XLV +15.5%). 1 year: +151.4% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: SRZN, SPY and XLV · as of 4 Nov 2026
3.1M shares were sold short at the 15 Oct 2026 settlement, 27.0% of the 11.6M shares outstanding; covering them would take 4.8 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
The 4 Nov 2026 close of $31.65 was 28.1% above its 50-day average ($24.70) and 25.3% above its 200-day average ($25.26). It has closed above the 200-day for 12 sessions, since 20 Oct 2026. The 50-day average crossed below the 200-day on 6 Aug 2026, 63 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
4 Nov 2026 volume of 231.1K shares was 0.2× the average of the 30 sessions before it (936.8K), as the price rose 5.1%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026
Closed at $31.65 on 4 Nov 2026: 16.3% below the 52-week high of $37.83 (25 Sep 2026) and 175.0% above the low of $11.51 (7 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
September 24, 2026
+108.42%April 1, 2024
−35.71%February 9, 2023
+46.75%